{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:32:56Z","timestamp":1761597176753,"version":"3.37.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.neuroscience.2009.11.053","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T08:20:29Z","timestamp":1260174029000},"page":"145-156","source":"Crossref","is-referenced-by-count":33,"title":["Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism"],"prefix":"10.1016","volume":"166","author":[{"given":"V.","family":"Knott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2009.11.053_bib1","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1176\/ajp.150.12.1856","article-title":"Normalization of auditory physiology by cigarette smoking in schizophrenia patients","volume":"150","author":"Adler","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib2","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1176\/appi.ajp.161.10.1822","article-title":"Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients","volume":"161","author":"Adler","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-3223(88)90273-9","article-title":"Modulation of the gating evoked potentials by norepinephrine: pharmacological evidence obtained using a selective neurotoxin","volume":"24","author":"Adler","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0006-3223(86)90244-1","article-title":"Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol","volume":"21","author":"Adler","year":"1986","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0006-3223(92)90073-9","article-title":"Normalization by nicotine of deficient sensory gating in the relatives of schizophrenics","volume":"32","author":"Adler","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib5a","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2007.07.030","article-title":"Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia","volume":"100","author":"AhnAllen","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1461145707007948","article-title":"Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia","volume":"11","author":"Amar","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/6.4.577","article-title":"A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia","volume":"6","author":"Arinami","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-9081-2-6","article-title":"Exploration of auditory P50 gating in schizophrenia by way of difference waves","volume":"2","author":"Arnfred","year":"2006","journal-title":"Behav Brain Funct"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archpsyc.55.4.362","article-title":"Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism","volume":"55","author":"Arnsten","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0006-3223(87)90188-0","article-title":"Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses","volume":"22","author":"Baker","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib10a","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.npp.1301423","article-title":"The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonspsychiatric controls","volume":"33","author":"Barr","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.01.015","article-title":"Neurobiology of nicotine addiction: implications for smoking cessation treatments","volume":"121","author":"Benowitz","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1471-4159.1988.tb10600.x","article-title":"Evidence that tobacco smoking increased the density of (\u2212)\u2014[3H] nicotine binding site in human brain","volume":"50","author":"Benwell","year":"1988","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/npp.2009.52","article-title":"Dopamine genes and nicotine dependence in treatment-seeking and community smokers","volume":"34","author":"Bergen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-3223(90)90648-L","article-title":"Auditory sensory gating in hippocampal neurons: a model system in the rat","volume":"27","author":"Bickford-Wimer","year":"1990","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(20000214)90:4<299::AID-AJMG7>3.0.CO;2-Y","article-title":"Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking","volume":"90","author":"Bierut","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.psychres.2004.01.007","article-title":"Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients","volume":"126","author":"Boutros","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2004.01.004","article-title":"Meta-analysis of the P300 and P50 waveforms in schizophrenia","volume":"70","author":"Bramon","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib20","first-page":"224","article-title":"The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood","volume":"6","author":"Cinciripini","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0920-9964(97)00122-9","article-title":"Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects","volume":"30","author":"Clementz","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s002210100744","article-title":"Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia","volume":"139","author":"Clementz","year":"2001","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib23","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1046\/j.1471-4159.1999.0731590.x","article-title":"Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungaro toxin and nicotine binding in thalamus","volume":"73","author":"Court","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(01)02454-5","article-title":"Enhancement of auditory sensory gating and stimulus-bound gamma band (40 Hz) oscillations in heavy tobacco smokers","volume":"317","author":"Crawford","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.psychres.2004.05.009","article-title":"Suppression of P50 evoked potential component, schizotypal beliefs and smoking","volume":"128","author":"Croft","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib26","first-page":"1","article-title":"Haloperidol differentially modulates prepulse inhibition and P50 suppression in healthy humans stratified for low and high gating levels","volume":"33","author":"Csomor","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings","volume":"155","author":"Dalack","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.tpj.6500447","article-title":"Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomized clinical trial of transdermal nicotine patch","volume":"8","author":"David","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/14622200701705027","article-title":"Bupropion efficiency for smoking cessation is influenced by the DRD2 Taq IA polymorphism: analysis of pooled data from two clinical trials","volume":"9","author":"David","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib30","article-title":"The genetics of smoking and nicotine addiction","author":"Davies","year":"2009","journal-title":"S D Med"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib31","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0306-4522(01)00183-X","article-title":"Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell","volume":"105","author":"De Bruin","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib34","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.npp.1300466","article-title":"Evidence of association between smoking and \u03b17 nicotinic receptor subunit gene in schizophrenia patients","volume":"29","author":"De Luca","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2007.04.028","article-title":"A meta analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups","volume":"97","author":"De Wilde","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.schres.2008.06.004","article-title":"The association between schizophrenia and smoking: unexplained by either the illness or the prodromal period","volume":"104","author":"Diaz","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib36a","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1369-1600.2008.00130.x","article-title":"Nicotine self-medication of cognitive-attentional processing","volume":"14","author":"Evans","year":"2009","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib37b","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1601-183X.2008.00445.x","article-title":"Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators","volume":"8","author":"Evans","year":"2009","journal-title":"Genes Brain Behav"},{"year":"1975","series-title":"Manual of the Eysenck personality questionnaire","author":"Eysenck","key":"10.1016\/j.neuroscience.2009.11.053_bib37"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2008.08.025","article-title":"The selective nicotinic acetylcholine receptor \u03b17 agonist JN403 is active in animal models of cognitions, sensory gating, epilepsy and pain","volume":"56","author":"Feverbach","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/schbul\/13.4.669","article-title":"Neurobiological studies of sensory gating in schizophrenia","volume":"13","author":"Freedman","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib40","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/archpsyc.1996.01830120052009","article-title":"Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects: human recordings, computer simulation, and an animal model","volume":"50","author":"Freedman","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0920-9964(01)00348-6","article-title":"Input dysfunction, schizotypy, and genetic models of schizophrenia","volume":"54","author":"Freedman","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib42","first-page":"537","article-title":"Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients","volume":"18","author":"Freedman","year":"1983","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.94.2.587","article-title":"Linkages of a neurophysiological deficit in schizophrenia to chromosome 15 locus","volume":"94","author":"Freedman","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C","article-title":"Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha 7-nicotinic acetylcholine receptor subunit gene (CHRNA7)","volume":"105","author":"Freedman","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11920-003-0032-2","article-title":"The genetics of sensory gating deficits in schizophrenia","volume":"5","author":"Freedman","year":"2003","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0920-9964(91)90035-P","article-title":"Elementary neuronal dysfunctions in schizophrenia","volume":"4","author":"Freedman","year":"1991","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1469-8986.2007.00524.x","article-title":"Range of sensory gating values and test\u2013retest reliability in normal subject","volume":"44","author":"Fuerst","year":"2007","journal-title":"Psychophysiology"},{"issue":"Suppl 4","key":"10.1016\/j.neuroscience.2009.11.053_bib48a","doi-asserted-by":"crossref","first-page":"S523","DOI":"10.1080\/14622200701685039","article-title":"Smoking to self-medicate attentional and emotional dysfunctions","author":"Gehricke","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/14622200500125245","article-title":"Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid information processing","volume":"7","author":"Gilbert","year":"2005","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.1995.tb38132.x","article-title":"Architecture of the prefrontal cortex and the central executive","volume":"769","author":"Goldman-Rakic","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0074-7742(06)78002-3","article-title":"The dopamine system in the pathophysiology of schizophrenia: a basic science perspective","volume":"78c","author":"Goto","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib53","first-page":"778","article-title":"The human dopamine D2 receptor gene is located on chromosome 11 at 822-q23 and identifies a TaqI RFLP","volume":"45","author":"Grandy","year":"1989","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib54","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/2.12.2197-a","article-title":"PCR detection of other TaqA RFLP at the DRD2 locus","volume":"2","author":"Grandy","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib55","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0013-4694(83)90135-9","article-title":"A new method for off-line removal of ocular artifact","volume":"55","author":"Gratton","year":"1983","journal-title":"Electoencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0006-3223(02)01673-6","article-title":"Neuronal substrates of sensory gating within the human brain","volume":"53","author":"Grunwald","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8760(00)00120-3","article-title":"Mid-latency evoked potentials in self-reported impulsive aggression","volume":"40","author":"Houston","year":"2001","journal-title":"Int J Psychophysiol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib58","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mp.4001443","article-title":"The promoter-194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit","volume":"9","author":"Hovy","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.57.1.3","article-title":"Metabolism and disposition kinetics of nicotine","volume":"57","author":"Hukkanen","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib61","first-page":"377","article-title":"Effects of P50 temporal variability of sensory gating in schizophrenia","volume":"139","author":"Jin","year":"1997","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00008571-200402000-00002","article-title":"Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch","volume":"14","author":"Johnstone","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.mp.4000532","article-title":"Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers","volume":"4","author":"J\u00f6nsson","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib63a","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0272-7358(97)00032-9","article-title":"Smoking and attention: a review and re-formulation of the stimulus-filter hypothesis","volume":"17","author":"Kassel","year":"1997","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FPC.0b013e3282f3ef8c","article-title":"TaqIA polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers","volume":"18","author":"Kim","year":"2008","journal-title":"Pharmacocogenet Genomics"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0001-6918(99)00004-9","article-title":"Prefrontal cortex regulates inhibition and excitation in distributed neural networks","volume":"101","author":"Knight","year":"1999","journal-title":"Acta Psychol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib66","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuroimage.2008.10.002","article-title":"Sensory gating and source analysis of the auditory P50 in low and high suppressors","volume":"44","author":"Knott","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/155005940904000108","article-title":"Nicotine and attention: event-related potential investigations in nonsmokers","volume":"40","author":"Knott","year":"2009","journal-title":"Clin EEG Neurosci"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2004.12.016","article-title":"Topisetron improves deficits in auditory P50 suppression in schizophrenia","volume":"76","author":"Koike","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib69","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neuroimage.2006.12.011","article-title":"Generators of the intracranial P50 responses in auditory sensory gating","volume":"35","author":"Korzyukov","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib70","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","article-title":"Nicotine use in schizophrenia: the self-medication hypothesis","volume":"29","author":"Kumari","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib71","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.euroneuro.2008.07.010","article-title":"TaqIA polymorphism in the D2 receptor gene as a predictor of clinical response to aripiprazole","volume":"18","author":"Kwon","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1461145704004389","article-title":"Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficiency for positive and negative symptoms and social function","volume":"7","author":"Lane","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib73","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archpsyc.59.12.1085","article-title":"Association of promoter variants in the 7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia","volume":"59","author":"Leonard","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib74","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/(SICI)1096-8628(19980710)81:4<308::AID-AJMG6>3.0.CO;2-P","article-title":"Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH genetics initiative","volume":"1","author":"Leonard","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1037\/0278-6133.18.1.14","article-title":"Evidence suggesting the role of genetic factors in cigarette smoking","volume":"18","author":"Lerman","year":"1999","journal-title":"Health Psychol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib75a","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0893-133X(96)00018-8","article-title":"Nicotine-haloperidol interactions and cognitive performance in schizophrenics","volume":"15","author":"Levin","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib76","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00000441-200310000-00003","article-title":"The genetics of smoking related behavior: a brief review","volume":"326","author":"Li","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib77","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11920-006-0016-0","article-title":"The genetics of nicotine dependence","volume":"8","author":"Li","year":"2006","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11920-999-0008-y","article-title":"Human and animal studies of schizophrenia-related gating deficits","volume":"1","author":"Light","year":"1999","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1566-2772(03)00018-5","article-title":"Sensory gating deficits in schizophrenia: can we parse the effects of medication, nicotine use, and changes in clinical status?","volume":"3","author":"Light","year":"2003","journal-title":"Clin Neurosci Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib80","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1176\/appi.ajp.157.5.767","article-title":"Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications","volume":"157","author":"Light","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib81","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0006-3223(99)00034-7","article-title":"Amphetamine disrupts P50 suppression in normal subjects","volume":"46","author":"Light","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib82","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","article-title":"Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia","volume":"27","author":"Lodge","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib83","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biopsych.2006.11.030","article-title":"Effect of catechol O-methyltransferase val(158)met polymorphism on the P50 gating endophenotype in schizophrenia","volume":"62","author":"Lu","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib84","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1176\/appi.ajp.161.5.780","article-title":"Pharmacogenetics of psychotropic drug response","volume":"161","author":"Malhotra","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib85","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.npp.1301556","article-title":"Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and P50 suppression measures of sensorimotor and sensory gating in human","volume":"33","author":"Mann","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(25)21452-5","article-title":"Genetics of nicotine response in four inbred strains of mice","volume":"226","author":"Marks","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroimage.2008.08.025","article-title":"The neural networks underlying auditory sensory gating","volume":"44","author":"Mayer","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.bjp.0705401","article-title":"Partial agonist behaviour depends upon the level of nociceptin\/orphanin FQ receptor expression: studies using ecdysone-inducible mammalian expression system","volume":"140","author":"McDonald","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2006.03.040","article-title":"Auditory inhibitory gating in medial prefrontal cortex: single unit and local field potential analysis","volume":"141","author":"Mears","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biopsych.2005.12.011","article-title":"Effects of nicotine vary across two auditory evoked potentials in the mouse","volume":"62","author":"Metzger","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib91","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00422-002-0372-8","article-title":"Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia","volume":"88","author":"Moxon","year":"2003","journal-title":"Biol Cybern"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib92","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00422-002-0373-7","article-title":"Inhibitory control of sensory gating in a computer model of the CA3 region of the hippocampus","volume":"88","author":"Moxon","year":"2003","journal-title":"Biol Cybern"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib94","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1016\/j.euroneuro.2008.04.002","article-title":"Schizophrenia: from developmental deviance to dopamine dysregulation","volume":"18","author":"Murray","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib95","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-3223(95)00134-4","article-title":"Developmental and genetic influences on the P50 sensory gating phenotype","volume":"15","author":"Myles-Worsley","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib95a","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<544::AID-AJMG20>3.0.CO;2-V","article-title":"Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families","volume":"88","author":"Myles-Worsley","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-3223(95)00371-1","article-title":"Gating of auditory P50 in schizophrenics: unique effects of clozapine","volume":"40","author":"Nagamoto","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000026553","article-title":"Auditory P50 in schizophrenics on clozapine: improved gating parallels elevated improvement and changes in plasma 2-methoxy-4-hydroxyphenylglycol","volume":"39","author":"Nagamoto","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib99","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/archpsyc.1991.01810310066012","article-title":"Allelic associations of the dopamine receptor gene with receptor binding characteristics in alcoholism","volume":"48","author":"Noble","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/(SICI)1096-8628(19970418)74:2<162::AID-AJMG9>3.0.CO;2-W","article-title":"D2 dopamine receptor polymorphism and brain regional metabolism","volume":"74","author":"Noble","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib101","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","article-title":"Proof of concept trial of an alpha 7 nicotinic agonist in schizophrenia","volume":"63","author":"Olincy","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib102","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/026988110401800310","article-title":"Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating","volume":"18","author":"Oranje","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Patterson","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib104","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psychres.2007.02.009","article-title":"P50 sensory gating ratios in schizophrenics and controls: a review and data analysis","volume":"158","author":"Patterson","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib105","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neuroscience.2006.11.003","article-title":"Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma","volume":"144","author":"Phillips","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib106","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviours related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib107","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.mp.4000350","article-title":"The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers","volume":"3","author":"Pohjalainen","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib108","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/schbul\/sbj050","article-title":"Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia","volume":"32","author":"Potter","year":"2006","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00213-006-0394-3","article-title":"\u03b14\u03b22 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA\/2 mouse model of sensory gating","volume":"187","author":"Radek","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.mp.4001140","article-title":"The -2bp deletion in exon 6 of the \u201calpha 7-like\u201d nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit","volume":"2","author":"Raux","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib111","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1037\/0278-6133.18.1.7","article-title":"A genetic association for cigarette smoking behavior","volume":"18","author":"Sabol","year":"1999","journal-title":"Health Psychol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib112","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1517\/14622416.5.6.691","article-title":"Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia\u2014an update","volume":"5","author":"Scharfetter","year":"2004","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib113","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.6828889","article-title":"Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo","volume":"220","author":"Schwartz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib114","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/261155a0","article-title":"Lesion of ascending dopamine pathways decrease forebrain glucose uptake","volume":"261","author":"Schwartz","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1126\/science.462184","article-title":"Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat","volume":"205","author":"Schwartz","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib116","first-page":"606","article-title":"Effects of DRD2\/ANKKI gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients","volume":"43","author":"Shen","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib117","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.neuroscience.2005.03.027","article-title":"Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials","volume":"133","author":"Siegel","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib118","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00213-002-1285-x","article-title":"Clozapine improves deficient inhibitory auditory processing in DBA\/2 mice via a nicotinic cholinergic mechanism","volume":"165","author":"Simosky","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1568007024606168","article-title":"Nicotinic agonists and psychosis","volume":"1","author":"Simosky","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib119a","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(02)00324-X","article-title":"Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia","volume":"27","author":"Smith","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1369-1600.2007.00058.x","article-title":"Association between dopamine transporter genotypes and smoking cessation: a meta-analysis","volume":"12","author":"Stapleton","year":"2007","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0893-133X(95)00178-G","article-title":"Genetic correlation of inhibitory gating of hippocampal auditory response and \u03b1-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains","volume":"15","author":"Stevens","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib122","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s002130050573","article-title":"Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice","volume":"136","author":"Stevens","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib123","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0091-3057(96)00466-2","article-title":"Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory glutens in two animal models","volume":"57","author":"Stevens","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib124","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004060170053","article-title":"Association between TaqIA dopamine DL receptor polymorphism and therapeutic response to bromperidol: a preliminary report","volume":"251","author":"Suzuki","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-200006000-00007","article-title":"The relationship between dopamine D2 receptor polymorphism at the TaqIA locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients","volume":"10","author":"Suzuki","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib126","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S1461145707008103","article-title":"Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study","volume":"11","author":"Takahashi","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib127","doi-asserted-by":"crossref","first-page":"420","DOI":"10.47102\/annals-acadmedsg.V38N5p420","article-title":"Cognitive dysfunction in schizophrenia: a perspective from the clinic to genetic brain mechanisms","volume":"38","author":"Tan","year":"2009","journal-title":"Ann Acad Med Singapore"},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2009.11.053_bib128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/cercor\/bhm069","article-title":"Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia","volume":"17","author":"Tan","year":"2007","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib129","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/schbul\/sbn049","article-title":"Neurophysiologic endophenotypes across bipolar and schizophrenia psychosis","volume":"34","author":"Thaker","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008571-199712000-00006","article-title":"D2 dopamine receptor gene (DRD2) TaqIA polymorphism: reduced dopamine D2 receptor binding in the human brain striatum associated with the A1 allele","volume":"7","author":"Thompson","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib131","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1037\/0278-6133.25.2.190","article-title":"An association between DATI polymorphism and smoking behavior in young adults, from the national longitudinal study of adolescent health","volume":"25","author":"Timberlake","year":"2006","journal-title":"Health Psychol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib132","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1744-9081-3-22","article-title":"Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study","volume":"3","author":"Ton","year":"2007","journal-title":"Behav Brain Function"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib133","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-9964(94)90067-1","article-title":"Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings","volume":"12","author":"Waldo","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib134","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpsycho.2005.03.024","article-title":"P50 sensory gating: impact of high vs. low schizotypal personality and smoking status","volume":"60","author":"Wan","year":"2006","journal-title":"Int J Psychophysiol"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psychres.2006.01.020","article-title":"Early and late auditory sensory gating: moderating influences from schizotypal personality, tobacco smoking status, and acute smoking","volume":"151","author":"Wan","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib136","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(01)01252-5","article-title":"Prefrontal neurons and the genetics of schizophrenia","volume":"50","author":"Weingberger","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib137","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-0173(03)00205-4","article-title":"Genetics of human prefrontal function","volume":"43","author":"Winterer","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib138","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.tins.2004.08.002","article-title":"Genes, dopamine and cortical signal-to-noise ratio in schizophrenia","volume":"27","author":"Winterer","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2009.11.053_bib140","first-page":"356","article-title":"Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone","volume":"3","author":"Yamanouchi","year":"2003","journal-title":"J Psychopharmacol"},{"year":"1994","series-title":"Behavioural experience and biological basis of sensation seeking","author":"Zuckerman","key":"10.1016\/j.neuroscience.2009.11.053_bib141"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209019356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209019356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T17:23:24Z","timestamp":1739467404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452209019356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0306452209019356"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2009.11.053","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}